Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Copaxone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 176,246Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA warns of allergic reactions with multiple sclerosis drugs
    FDA warns of allergic reactions with multiple sclerosis drugs

    23 Jan 2025

    // FDA

    https://www.fda.gov/safety/medical-product-safety-information/copaxone-glatopa-glatiramer-acetate-drug-safety-communication-fda-adds-boxed-warning-about-rare#:~:text=ISSUE%3A%20The%20FDA%20is%20warning,with%20multiple%20sclerosis%20(MS).

    FDA
    23 Jan 2025
    Share Share
    Teva hit with €463M fine over Copaxone misconduct claims in EU
    Teva hit with €463M fine over Copaxone misconduct claims in EU

    30 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/teva-slapped-eu463m-fine-over-accusations-it-stymied-copaxone-competition-europe

    FIERCE PHARMA
    30 Oct 2024
    Share Share
    Teva to pay $450M to settle longstanding kickback allegations
    Teva to pay $450M to settle longstanding kickback allegations

    14 Oct 2024

    // FIERCE PHARMA

    https://fiercepharma.com/pharma/teva-hands-over-450m-resolve-kickback-lawsuits-involving-ms-drug-copaxone-and-generics

    FIERCE PHARMA
    14 Oct 2024
    Share Share
    Synthon Pharma`s Generics Glatiramer Acetate Receives Approval in US
    Synthon Pharma`s Generics Glatiramer Acetate Receives Approval in US

    25 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206873

    FDA
    25 Sep 2024
    Share Share
    Synthon`s Generics Glatiramer Acetate Receives Approval in US
    Synthon`s Generics Glatiramer Acetate Receives Approval in US

    25 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203857

    FDA
    25 Sep 2024
    Share Share
    Teva Faces Fresh Copaxone Kickbacks Case From Medicare Providers
    Teva Faces Fresh Copaxone Kickbacks Case From Medicare Providers

    20 Aug 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/teva-faces-fresh-copaxone-kickback-lawsuit-medicare-providers-amid-ongoing-doj-case

    FIERCE PHARMA
    20 Aug 2024
    Share Share